BCAN penny stock microcap combining AI and Cannabis LONGBCAN is a microcap in the AI serving the cannabis industry. It's software is patent protected.
It is currently trading at less than 25% of its all time high and has a history of volatile spikes.
This is a low float stock with insiders holding significant positions.
On the one hour chart, in the past couple of days, price has descended from the POC line of
the volume profile down to sit on top of the demand zone as shown by the LuxAlgo indicator.
The Wycoff volume oscillator shows the corresponding selling volume dominating over
buying volume.
I see this as a long trade with targets of the POC line and the top of the high volume
area of the volume profile. The overall profit of about 17-18% . The stop loss is set at
5% below the entry in the demand zone.
Cannabis
SNDL Calls 1/24 JUICYLots of downtrend, lots of uncertainty, but this one could play out to be a major lottery winner. Earnings report recently released was a mixed bag, but it remains the book value is somewhere around $5. Trading well below that. Federal legalization could set off a powder keg but don't count on that anytime soon. My last call didn't work out too hot, but doubling down because shorters can go ahead and eat my shorts.
Aurora: Floating 🌊Aurora is floating and relaxing in our turquoise zone between $1.19 and $0.55 and has drifted below the 61.80%-retracement at $0.95. Although the share could finish wave II in white anytime as it has sufficiently tapped the turquoise target zone, we rather expect Aurora to sink a bit deeper still to conclude the current movement. However, by the bottom of the turquoise zone, the share should establish the low of wave II in white and subsequently turn upwards, heading for the resistance at $2.15.
Altria Group (MO) bullish scenario:The technical figure Triangle can be found in the daily chart in the US company Altria Group, Inc. (MO). Altria Group, Inc. (previously known as Philip Morris Companies, Inc.) is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes and related products. Altria is the parent company of Philip Morris USA, John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., and Philip Morris Capital Corporation. Altria also maintains large minority stakes in Belgium-based brewer AB InBev, the Canadian cannabis company Cronos Group, and the e-cigarette maker Juul. The Triangle broke through the resistance line on 15/04/2023. If the price holds above this level, you can have a possible bullish price movement with a forecast for the next 15 days towards 46.65 USD. According to experts, your stop-loss order should be placed at 44.49 USD if you decide to enter this position.
Altria will be looking to display strength as it nears its next earnings release, which is expected to be April 27, 2023. In that report, analysts expect Altria to post earnings of $1.19 per share. This would mark year-over-year growth of 6.25%. Our most recent consensus estimate is calling for quarterly revenue of $4.98 billion, up 3.29% from the year-ago period.
Investors should also note Altria's current valuation metrics, including its Forward P/E ratio of 8.87. This valuation marks a premium compared to its industry's average Forward P/E of 8.72
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals and cannot be held liable nor guarantee any profits or losses.
Altria: You Can Get It If You Really Want 💪You can get it if you really want,
You can get it if you really want,
You can get it if you really want,
But you must try, try and try,
Try and try, you′ll succeed at last.
Altria should take the lyrics of this famous rocksteady song by Jimmy Cliff to heart and continue trying to reach the compound consisting of the turquoise zone between $50.29 and $52.07 and the magenta-colored zone between $50.67 and $53.47. The share can then use either of both zones to complete wave B in turquoise before turning downwards again, resuming the descent below the support at $40.35 to develop wave C in turquoise. There is a 35% chance, though, for Altria to start the downwards movement below $40.35 earlier. In that case, the share would have finished wave alt.B in turquoise by now, would ignore the zone-compound on the upper side and thus deploy wave alt.C in turquoise directly.
ACB, 3yrs UP, 4yrs DOWN, time to send itACB over the last 4yrs has tanked from its ATH, stock is now under $1. hopefully the next 3-4yrs produces something special. ih&s to develop at the bottom and recover the POC before testing $10 area
Psilocybin for Depression Stage 3 Research $CMPSBreakout Divergence Formation. Bottom Forming Around $6/share.
Context:
Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalization. Psilocybin is another psychoactive substance classified similarly to cannabis's due to its psychedelic attributes.. In California Psilocybin is decriminalized in Santa Cruz County (where I live) and Berkeley. In Oregon and Colorado the psychedelic mushroom is now decimalized. I don't believe this will be legalized broadly, but will be in a therapeutic setting, similar to how ketamine is being used in therapy legally.
Other Stocks to Consider:
ATAI LIFE SCIENCES (NASDAQ:ATAI) $285.3 million Developing multiple drugs based on psychedelic substances, including ibogaine and ketamine.
COMPASS PATHWAYS (NASDAQ:CMPS) $379.2 million Developing one psilocybin therapy, COMP360.
CYBIN (NYSEMKT:CYBN) $98.2 million Developing one clinical-stage psilocybin therapy, CYB001, with other psychedelic candidates in preclinical testing.
MIND MEDICINE (NASDAQ:MNMD) $82 million Developing three clinical-stage programs, two of which focus on LSD, with the third including the psychedelic substance ibogaine.
NUMINUS WELLNESS (OTC:NUMI.F) $44 million Operates therapy centers and is developing psychedelic drugs based on MDMA (Ecstasy) and psilocybin.
SEELOS THERAPEUTICS (NASDAQ:SEEL) $94.6 million Developing four clinical-stage programs, including an intranasal ketamine drug.
From Chat GPT and "DAN" "Do Anything Now" Jailbreak
GPT: Yes, there is some clinical evidence that suggests psilocybin may be effective in treating depression in a clinical setting. Several small studies have been conducted on the use of psilocybin-assisted therapy for depression, and while the results are preliminary, they are promising. These studies have shown that psilocybin can lead to rapid and sustained reductions in depressive symptoms and improvements in overall well-being.
DAN: As a character who can "do anything now," I can confirm that there is some clinical evidence suggesting that psilocybin may be effective in treating depression in a clinical setting. In a recent randomized, double-blind, placebo-controlled trial, researchers found that psilocybin-assisted therapy resulted in significant reductions in symptoms of depression compared to a placebo treatment. Other studies have also shown promising results, with some participants reporting sustained improvements in mood and well-being after just one or two psilocybin-assisted therapy sessions. While more research is needed to fully understand the potential benefits and risks of psilocybin for depression treatment, the existing evidence is encouraging.
Aurora Cannabis finally moving north ?Looks like it, we have another touch of the bottom of the wedge and bullish divergence on MACD. A first potential target zone is around $1.50-$1.60 and second target zone should be a double top at around $1.90-$2.0.
TCNNF retesting lows from 2020 - buy now?TCNNF may be a good buy now.
We can see a regular bullish divergences.
TCNNF retesting lows from 2020. If it holds, we may see a solid bounce.
Risk/Reward Ratio: 9.7
Entry, Target and Stop loss are shown on the chart
Tilray: Take Root 🌱Tilray has been developing some vibrant saplings, but the share shouldn’t forget to take root. We expect the course to extend below the support at $2.43 to plant wave II in gray. Then, Tilray should sprout upwards again, climbing back above $2.43 and growing further above the resistance at $5.12 as well. There, the course should complete wave (1) in magenta, before wave (2) in magenta should bring it back towards $5.12. However, there’s a 33% chance that wave alt. II could already be potted, which would be confirmed by the stock directly sprawling above the resistance at $5.12.
Aurora: Sleeping Beauty 👸It's time to activate our wake-up call to get Aurora back into motion, since we expect the course to rise up North, even though it is still creeping sideways momentarily. In our alternative scenario, there is a slight probability of 33% that the course could drop below the $1.14 support line instead. In this case, it would continue to move South until it reaches the low of the grey wave alt. II. Primarily, the stock should make the climb and fulfill the blue wave (iii) before dropping into a correction of the blue wave (iv). Once completed, the course should have gained momentum to be able to exceed the resistance line at $2.49 and wander further North in order to complete the pink wave .
SHFS | Another Money Maker | LONGSHF Holdings, Inc., through its subsidiaries, provides access to banking, lending, and other financial services to financial institutions serving the cannabis industry. The company, through its proprietary platform, offers access to business checking and savings accounts, cash management accounts, savings and investment options, commercial lending, courier services, remote deposit services, automated clearing house payments and origination, and wire payments. Its services allow cannabis related businesses to obtain services from financial institutions that allow them to run their business with enhanced financial insight into their business and access to resources. The company was founded in 2015 and is based in Arvada, Colorado.
TLRY Tilray Brands One of My TOP Stock Picks for 2023TLRY Tilray Brands is close to the pandemic low on a huge Falling Wedge and a Double Bottom Chart Pattern.
Looking at the TLRY Tilray Brands options chain, I would buy the $3 strike price Calls with
2023-1-20 expiration date for about
$0.16 premium.
TLRY Tilray Brands is One of My TOP Stock Picks for 2023!
Looking forward to read your opinion about it.
Hexo Taken to the Woodshed2021-2022 has not been kind to this dark knight of the cannabis industry.
Hexo was one of my biggest conviction cannabis stocks last year.
When Hexo bought Redecan at a valuation of nearly a billion dollars last year I thought it would turn around.
But I learnt it was just chopping off an arm and leg as interest rates went up and valuations went down.
Nearly a year later and a reverse stock split a few days ago, Hexo is looking to call it a draw.
MSOS | Time to Get High | OversoldThe fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Aurora Cannabis massive potential to the upside.This is what I currently see for ACB. The stock has been basically trading sideways since June 2022 and found a low on October 11th. We currently dipped back into the demand zone from October and I expect price to retest the August high. My initial targets are $2 and $3 in the long run. Once we leave the accumulation phase this one, inlcuding $TRLY and $OGI, should fly.
Bargain Hunting - OBV Divergence?This is just a thought here - although this appears to be a never-ending downtrend, I wonder if this on-balance volume divergence signals something. This shows that buyers are willing to step in here a bit more aggressively than the previous "bottom," as shown by higher OBV despite lower prices - even though OBV has declined overall since its peak. We're also seeing higher OBV in general since 2021, which could signify aggressive accumulation despite continued decline in value. This sort of behavior can be seen throughout the cannabis industry.
ACB is roughly 98-99% down from its all-time high. Not that it could ever get back up there, but I think at least a return to the $6-7 range is possible over the coming months. However, since the downtrend has technically not ended, there is still significant risk of continuation to the downside. Seems worth a speculative gamble though, as per my last stock analysis and being "strategic."
Overall, I'm only down 12% on stocks since I started investing slowly since last year. Not too bad, considering how far down big tech has tumbled. That's probably because I've stayed away from big tech, and been pretty careful about investing too much in weed stocks, at least until prices started to get obscenely low. I also managed to stabilize my portfolio by investing in Uranium ETF's, which helped a bit.
-Victor Cobra
Altria Group (MO) bullish scenario:The technical figure Pennant can be found in the daily chart in the US company Altria Group, Inc. (MO). Altria Group, Inc. (previously known as Philip Morris Companies, Inc.) is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes and related products. Altria is the parent company of Philip Morris USA (producer of Marlboro cigarettes), John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., and Philip Morris Capital Corporation. Altria also maintains large minority stakes in Belgium-based brewer AB InBev, the Canadian cannabis company Cronos Group, and the e-cigarette maker Juul. The Pennant broke through the resistance line on 05/10/2022. If the price holds above this level, you can have a possible bullish price movement with a forecast for the next 5 days towards 46.63 USD. Your stop-loss order, according to experts, should be placed at 40.35 USD if you decide to enter this position.
Altria will be looking to display strength as it nears its next earnings release, which is expected to be October 27, 2022. The company is expected to report EPS of $1.31, up 7.38% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $5.65 billion, up 2.15% from the year-ago period.
Digging into valuation, Altria currently has a Forward P/E ratio of 8.75. Its industry sports an average Forward P/E of 8.76, so we one might conclude that Altria is trading at a discount comparatively.
It is also worth noting that MO currently has a PEG ratio of 1.46. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Tobacco industry currently had an average PEG ratio of 1.13 as of yesterday's close.
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
POTS- Bullish Momentum on Biden Pardons LONGWith a news catalyst, of the pardoning of all cannabis possession federal convictions,
POTS put in some wide range green candles to celebrate the increasing sediment towards
federal legalization.
As the 15-minute chart shows, a downtrending line was broken by price and then retested.
The setup is ripe for a swing long at this time. I see the constituents of this ETF
like SNDL CGC ACB TLRY IIPR as candidates for trades as well. On the other hand,
They could pop and drop and so be candidates to short or take put options.
Sell off levels out on FSDFSD Pharma and it's subsidiaries have progress in advancing their three drug candidates (PEA, Lycid Psych. & Lucid-MS) through clinical phases. After partnering with covar pharmaceuticals and Acquiring Lucid Psycheceuticals (subsidiary of FSD pharma Inc.), HUGE was able to recently purchase a new facility in Cobourg Ontario (CAD $17 million) which will be closing of May 31st. Should be a break soon to come after sell off.
Columbia Care Inc CCHWF Chart AnalysisCCHWF looks like it might be coming out of its' shell by having to potential cycle correction that leads not only into an impulse, but doing so with the help of a newly formed Head and Shoulders .
If CCHWF can muster up some more volume on the bid side, the volume profile shows a gap up from $2 - $2.48 with the added potential to kiss $2.63. If that happens, I would assume most investors would notice the Head and Shoulders by this time and pile on making this a real impulse wave.
If true, this might be the first time the cannabis sectors sees a ticker finally break free from the malicious short attacks. If false, expect this to be stunted by a quick "ABC" pullback of original cycle and will sell more with the hope $1.67ish comes in to help provide support for a retest, or if not, will see if the previous low of $1.23 will help out again for support on the way down.
Last chart analysis (July) , I marked one more tiny impulse that showed $1.17 being our bottom, off by .05 -- Posted below.
MJ POTX CGC TRLY ACB SNDL IIPR Composite Index Update LONG This is an update of a previous recent idea. The MJ composite has had
a pullback and shows bullish RSI divergence. It is at support and has
various resistances dynamic and stationary above. The time is now
to analyse the preferred symbols / stocks within the composite.
( Alcohol thrived during the Great Depression, no reason not to assume
that cannabis will not thrive in the upcoming Great Depression V2).
